Loading clinical trials...
Loading clinical trials...
An Open-Label Phase 2 Study of HQK-1001 in Subjects With Beta Thalassemia Intermedia
Conditions
Interventions
Sodium 2,2 dimethylbutyrate
Locations
1
Lebanon
Chronic Care Center
Beirut, Lebanon
Start Date
May 1, 2012
Primary Completion Date
November 1, 2012
Completion Date
January 1, 2013
Last Updated
March 14, 2013
NCT06831799
NCT05883254
Lead Sponsor
Boston University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions